---
title: "Klarna Group plc Stock 12‑Month Price Target Raised to $21.44, Implies 41% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286798676.md"
description: "Klarna Group plc's stock price target has been raised to $21.44, indicating a potential upside of 41%. The average target from 18 analysts increased from $21.28 to $21.39, with a consensus rating of 'Buy' from 21 analysts, including 13 Buys and 8 Holds."
datetime: "2026-05-18T16:20:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286798676.md)
  - [en](https://longbridge.com/en/news/286798676.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286798676.md)
---

# Klarna Group plc Stock 12‑Month Price Target Raised to $21.44, Implies 41% Upside

-   According to estimates from 18 analysts, Klarna Group plc stock's average price target has risen from $21.28 to $21.39, with forecasts ranging from $17 to $30 per share
-   Based on the May 15 closing price, the updated target implies approximately 41% potential upside
-   Consensus rating remains at “Buy” across 21 covering analysts, with 13 Buys, 8 Holds and 0 Sells

Explore more price target data and ratings for Klarna Group plc on the , and track all previous and future analyst recommendations for Klarna Group plc in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [KLAR.US](https://longbridge.com/en/quote/KLAR.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Klarna Q1 revenue beats analyst estimates](https://longbridge.com/en/news/286409405.md)
- [Klarna Stock (KLAR) Rises despite Top Analyst Cut after 36% Selloff in 2025](https://longbridge.com/en/news/271330756.md)
- [KE Holdings Inc Stock 12‑Month Price Target Raised to $21.6, Implies 21% Upside](https://longbridge.com/en/news/286972711.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)